Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Blood pressure (BP) in people with the metabolic syndrome is particularly sensitive to salt intake, indicates research suggesting that sodium reduction might be effective in managing hypertension in people with multiple cardiometabolic risk factors.
The finding is reported by US researchers in The Lancet and is based on a dietary intervention study investigating the association between BP and salt sensitivity in 1906 Chinese adults.
At baseline all participants were free of diabetes but 283 had the metabolic syndrome. They received a low-sodium diet (51.3 mmol/day) for 7 days followed by a high-sodium diet (307.8 mmol/day) for 7 days, with BP being measured at baseline and throughout each intervention.
Jing Chen (Tulane University School of Medicine, New Orleans, Louisiana) and fellow investigators detected a “strong, positive, and significant’ association between the metabolic syndrome and salt sensitivity of BP, defined as a decrease in mean arterial blood pressure of >5 mmHg during low-sodium or an increase of >5 mmHg during high-sodium intervention.
After adjusting for multiple confounders, BP changes were significantly greater in people with the metabolic syndrome than in those without during both the low-sodium and high-sodium diets (p<0.0001 for all comparisons).
Furthermore, the likelihood of salt-sensitivity rose with increasing numbers of risk factors for the metabolic syndrome. Compared with those with no risk factors, participants with four or five risk factors had a 3.54-fold and 3.13-fold increased risk for high salt-sensitivity during the low-sodium and high-sodium diets, respectively.
Chen et al say that the underlying mechanism of increased salt sensitivity in individuals with the metabolic syndrome is not fully understood. One possibility is that insulin resistance and concomitant compensatory hyperinsulinemia might lead to sodium retention and extracellular fluid volume expansion, thereby increasing BP responses to sodium intake.
“A reduced intake of sodium could be beneficial in individuals with metabolic syndrome,” the investigators write. “We now need to establish the effect of prevention and treatment of metabolic risk factors on salt sensitivity of blood pressure.”
MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a part of Springer Science+Business Media. © Current Medicine Group Ltd; 2009
Read the abstract
© 2017 European Society of Cardiology. All rights reserved